Yahoo
    Shanghai - Delayed Quote CNY

    Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)

    19.78 -0.91 (-4.40%)
    At close: 3:00:00 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 603538.SS
    • Previous Close 20.69
    • Open 20.39
    • Bid 19.78 x --
    • Ask 19.79 x --
    • Day's Range 19.61 - 20.78
    • 52 Week Range 13.55 - 50.28
    • Volume 27,589,898
    • Avg. Volume 45,531,253
    • Market Cap (intraday) 6.724B
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) 56.51
    • EPS (TTM) 0.35
    • Earnings Date --
    • Forward Dividend & Yield 0.16 (0.75%)
    • Ex-Dividend Date Jul 9, 2026
    • 1y Target Est --

    Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin ca, atorvastatin ca, pregabalin, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous, gastrointestinal and digestive tracts, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.

    www.menovopharm.com

    2,370

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Ningbo Menovo Pharmaceutical Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    603538.SS
    44.73%
    SSE Composite Index (000001.SS)
    9.09%

    1-Year Return

    603538.SS
    17.39%
    SSE Composite Index (000001.SS)
    9.26%

    3-Year Return

    603538.SS
    38.35%
    SSE Composite Index (000001.SS)
    19.05%

    5-Year Return

    603538.SS
    41.45%
    SSE Composite Index (000001.SS)
    3.13%

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      6.04%

    • Return on Assets (ttm)

      2.10%

    • Return on Equity (ttm)

      4.07%

    • Revenue (ttm)

      1.83B

    • Net Income Avi to Common (ttm)

      110.43M

    • Diluted EPS (ttm)

      0.35

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      579.72M

    • Total Debt/Equity (mrq)

      26.11%

    • Levered Free Cash Flow (ttm)

      -235.56M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    603456.SS Zhejiang Jiuzhou Pharmaceutical Co., Ltd
    15.03 -1.76%
    603520.SS Zhejiang Starry Pharmaceutical Co.,Ltd.
    8.08 +1.25%
    603707.SS Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
    8.20 +0.37%
    603127.SS Joinn Laboratories(China)Co.,Ltd.
    40.09 -9.85%
    603669.SS Lionco Pharmaceutical Group Co.,Ltd.
    5.19 -4.60%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: